Table 1 Characteristics of patients with EML4-ALK-positive NSCLC and the associated JAK2 and STAT6 protein expression
Case number | Smoking status | Histology (H&E) | pTNM | ALK/P-JAK2/P-STAT6 IHC at primary sites | ALK/P-JAK2/P-STAT6-IHC at metastatic sites |
|---|---|---|---|---|---|
1-147 | Non | AD | T2aN2M0 |  + / + / +  | –/–/– |
2-159 | Non | Mixed-AD | T1N2M0 |  + / ±  |  + / ±  |
3-161 | Non | Mixed-AD | T1N2M0 |  + / + / +  | –/–/– |
4-170 | Non | Ad + SCC | T2bN2M0 |  + / ±  | –/–/– |
5-177 | Non | Mixed -AD | T2aN1M0 |  + / + / +  |  + / ±  |
6-184 | Yes | Mixed -AD | T2aN1M1 |  + / + / +  |  + / ±  |
7-98 | Non | Mucinous BAC | T2aN0M0 |  + / + / +  | / |